Kelsen, David

Publications

Sort by

Co-Author Network

selected publications

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020 Academic Article GET IT
Times cited: 477
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 94
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial. The Lancet. Oncology. 2020 Academic Article GET IT
Times cited: 188
Reply to N. Fazio. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Letter GET IT
Times cited: 1
Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis. Clinical colorectal cancer. 2020 Academic Article GET IT
Times cited: 7
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. European journal of cancer (Oxford, England : 1990). 2019 Review GET IT
Times cited: 9
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer. The oncologist. 2019 Academic Article GET IT
Times cited: 9
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 10
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer. Cancer discovery. 2018 Academic Article GET IT
Times cited: 98
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 142
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2018 Academic Article GET IT
Times cited: 14
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of ¹⁸F-(2S,4R)-4-Fluoroglutamine. Radiology. 2018 Academic Article GET IT
Times cited: 66
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 221
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma. Cancer. 2018 Academic Article GET IT
Times cited: 82
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. European journal of cancer (Oxford, England : 1990). 2017 Academic Article GET IT
Times cited: 112
Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Annals of surgery. 2017 Academic Article GET IT
Times cited: 44
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. Cancer discovery. 2017 Academic Article GET IT
Times cited: 214
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Cancer. 2017 Academic Article GET IT
Times cited: 54
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Review GET IT
Times cited: 14
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. British journal of cancer. 2017 Academic Article GET IT
Times cited: 54
Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Academic Article GET IT
Times cited: 1081
Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016 Conference Paper GET IT
Times cited: 84
Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016 Conference Paper GET IT
Times cited: 56
Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016 Conference Paper GET IT
Times cited: 118
Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. Journal of gastrointestinal oncology. 2016 Academic Article GET IT
Times cited: 61
MEK inhibitor treatment is effective in a patient with metastatic carcinoma of the ampulla of Vater with BRAF and NRAS mutations shown by next-generation sequencing. 2016 GET IT
Times cited: 1
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma. Cancer. 2016 Academic Article GET IT
Times cited: 26
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. Gastroenterology. 2016 Academic Article GET IT
Times cited: 116
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Expert review of gastroenterology & hepatology. 2016 Review GET IT
Times cited: 39
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 149
Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015 Academic Article GET IT
Times cited: 145
Liver-directed conversion therapy in metastatic colon cancer. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Times cited: 2
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma. Clinical colorectal cancer. 2015 Academic Article GET IT
Times cited: 19
Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Academic Article GET IT
Times cited: 4135
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. American journal of clinical oncology. 2014 Academic Article GET IT
Times cited: 7
A woman with metastatic pancreatic neuroendocrine tumor. Gastrointestinal cancer research : GCR. 2014 Academic Article GET IT
Combined modality therapy in pancreatic adenocarcinoma: review and updates on a controversial issue. Current pharmaceutical design. 2014 Review GET IT
Times cited: 1
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 22
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of hepatology. 2013 Academic Article GET IT
Times cited: 75
Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Academic Article GET IT
Times cited: 36
Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2013 Academic Article GET IT
Times cited: 8
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. European journal of cancer (Oxford, England : 1990). 2013 Review GET IT
Times cited: 137
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of palliative medicine. 2013 Academic Article GET IT
Times cited: 71
A young woman with liver cancer. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Genomic dysregulation in gastric tumors. Journal of surgical oncology. 2012 Review GET IT
Times cited: 25
Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Annals of oncology : official journal of the European Society for Medical Oncology. 2012 Academic Article GET IT
Times cited: 255
A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. 2012 GET IT
Times cited: 1
A 72-year-old man with duodenal adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012 Academic Article GET IT
Times cited: 113
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis. Diseases of the colon and rectum. 2012 Academic Article GET IT
Times cited: 18
A case of advanced gastric cancer. 2012 GET IT
A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management. 2011 GET IT
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer. 2011 Academic Article GET IT
Times cited: 71
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer. 2011 Academic Article GET IT
Times cited: 64
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. The oncologist. 2011 Academic Article GET IT
Times cited: 202
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. 2011 GET IT
Times cited: 11
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. American journal of clinical oncology. 2011 Academic Article GET IT
Times cited: 81
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British journal of cancer. 2011 Academic Article GET IT
Times cited: 85
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer. 2011 Academic Article GET IT
Times cited: 83
Molecular classification of gastric cancer: a new paradigm. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 250
MET expression and amplification in patients with localized gastric cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011 Academic Article GET IT
Times cited: 131
Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer. 2011 GET IT
Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer. Gastrointestinal cancer research : GCR. 2011 Academic Article GET IT
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 174
A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus. Cancer. 2010 Academic Article GET IT
Times cited: 87
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Investigational new drugs. 2010 Academic Article GET IT
Times cited: 44
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies. Journal of thrombosis and haemostasis : JTH. 2010 Academic Article GET IT
Times cited: 35
Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. Journal of the National Comprehensive Cancer Network : JNCCN. 2010 Review GET IT
Times cited: 168
Advanced gastric cancer--slow but steady progress. Cancer treatment reviews. 2010 Review GET IT
Times cited: 132
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American journal of clinical oncology. 2009 Academic Article GET IT
Times cited: 16
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2009 Academic Article GET IT
Times cited: 39
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors. Cancer investigation. 2009 Academic Article GET IT
Times cited: 1
G3139 (Genasense) in patients with advanced merkel cell carcinoma. American journal of clinical oncology. 2009 Academic Article GET IT
Times cited: 34
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 41
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. Journal of the American College of Surgeons. 2008 Academic Article GET IT
Times cited: 76
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Investigational new drugs. 2008 Academic Article GET IT
Times cited: 4
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 109
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?. The American journal of surgical pathology. 2008 Academic Article GET IT
Times cited: 144
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer. Cancer chemotherapy and pharmacology. 2008 Academic Article GET IT
Times cited: 42
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity. 2007 GET IT
Times cited: 38
Systemic chemotherapy does not increase the risk of gastrointestinal perforation. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 9
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 95
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?. Annals of surgical oncology. 2007 Academic Article GET IT
Times cited: 87
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 81
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 74
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 434
Combined modality chemoradiation in elderly oesophageal cancer patients. British journal of cancer. 2007 Academic Article GET IT
Times cited: 61
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 73
Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Seminars in oncology. 2007 Review GET IT
Times cited: 70
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 412
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2006 Academic Article GET IT
Times cited: 48
Adjuvant Therapy for Stage II Colorectal Cancer: Who and with What?. Current treatment options in gastroenterology. 2006 Academic Article GET IT
Multimodality therapy of local regional esophageal cancer. Seminars in oncology. 2005 Review GET IT
Times cited: 11
Targeted therapies for esophageal cancer. The oncologist. 2005 Review GET IT
Times cited: 139
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers. American journal of clinical oncology. 2005 Academic Article GET IT
Times cited: 11
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 100
Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Letter GET IT
Times cited: 117
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 104
Pelvic CT in patients with esophageal cancer. AJR. American journal of roentgenology. 2005 Academic Article GET IT
Times cited: 13
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 1066
Small-cell carcinomas of the gastrointestinal tract: a review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Review GET IT
Times cited: 240
Combined modality therapy of esophageal cancer: changes in the standard of care?. Annals of surgical oncology. 2004 Editorial Article GET IT
Times cited: 11
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. British journal of cancer. 2004 Academic Article GET IT
Times cited: 117
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer. Anti-cancer drugs. 2004 Academic Article GET IT
Times cited: 8
Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 66
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 91
Combined modality therapy in esophageal cancer: the Memorial experience. Seminars in surgical oncology. 2003 Academic Article GET IT
Times cited: 17
Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer. Cancer investigation. 2003 Academic Article GET IT
Times cited: 21
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Annals of surgical oncology. 2002 Academic Article GET IT
Times cited: 58
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. The Journal of thoracic and cardiovascular surgery. 2002 Academic Article GET IT
Times cited: 73
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Annals of oncology : official journal of the European Society for Medical Oncology. 2002 Academic Article GET IT
Times cited: 97
Irinotecan, cisplatin, and radiation in esophageal cancer. Oncology (Williston Park, N.Y.). 2002 Review GET IT
Times cited: 14
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 147
[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2002 Academic Article GET IT
Times cited: 1
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 1338
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 19
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Annals of surgical oncology. 2001 Academic Article GET IT
Times cited: 109
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 201
Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Letter GET IT
Times cited: 9
Preoperative chemoradiotherapy for esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Editorial Article GET IT
Times cited: 36
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma. Cancer. 2001 Academic Article GET IT
Times cited: 77
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 1
Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 1
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. Journal of the National Cancer Institute. 2000 Academic Article GET IT
Times cited: 331
Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 37
Surrogate endpoints in assessment of new drugs in colorectal cancer. Lancet (London, England). 2000 Comment GET IT
Times cited: 8
Multimodality therapy of esophageal cancer: an update. Cancer journal (Sudbury, Mass.). 2000 Review GET IT
Times cited: 26
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma. Cancer journal (Sudbury, Mass.). 2000 Academic Article GET IT
Times cited: 49
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer journal (Sudbury, Mass.). 2000 Academic Article GET IT
Times cited: 119
Neoadjuvant therapy of squamous cell carcinoma of the esophagus. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2000 Academic Article GET IT
Times cited: 7
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis. Cancer chemotherapy and pharmacology. 2000 Academic Article GET IT
Times cited: 62
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999 Academic Article GET IT
Times cited: 335
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. 1999 GET IT
Times cited: 82
Chemotherapy in esophageal cancer. Seminars in oncology. 1999 Review GET IT
Times cited: 135
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 248
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma. Cancer. 1999 Academic Article GET IT
Times cited: 13
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. Journal of surgical oncology. 1999 Academic Article GET IT
Times cited: 42
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. International journal of radiation oncology, biology, physics. 1999 Academic Article GET IT
Times cited: 135
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma. Cancer investigation. 1999 Academic Article GET IT
Times cited: 25
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. The New England journal of medicine. 1998 Academic Article GET IT
Times cited: 1209
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 44
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Academic Article GET IT
Times cited: 92
Irinotecan and cisplatin in upper gastrointestinal malignancies. Oncology (Williston Park, N.Y.). 1998 Review GET IT
Times cited: 18
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 189
Adjuvant chemotherapy in gastric adenocarcinomas. Cancer treatment and research. 1998 Review GET IT
Times cited: 1
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer. American journal of clinical oncology. 1997 Academic Article GET IT
Times cited: 15
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. Seminars in oncology. 1997 Academic Article GET IT
Times cited: 29
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma. Cancer. 1997 Academic Article GET IT
Times cited: 31
Combined modality therapy of gastric cancer. Surgical oncology clinics of North America. 1997 Review GET IT
Times cited: 6
Neoadjuvant therapy of esophageal cancer. Surgical oncology clinics of North America. 1997 Review GET IT
Times cited: 24
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene. 1997 Academic Article GET IT
Times cited: 32
Multimodality therapy for adenocarcinoma of the esophagus. Gastroenterology clinics of North America. 1997 Review GET IT
Times cited: 19
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 120
Adjuvant therapy for colorectal cancer. Current problems in surgery. 1997 Review GET IT
Times cited: 28
Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery. 1997 Academic Article GET IT
Times cited: 131
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Diseases of the colon and rectum. 1997 Academic Article GET IT
Times cited: 240
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 109
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1997 Academic Article GET IT
Times cited: 159
Adjuvant treatment of colorectal cancer. Annual review of medicine. 1997 Review GET IT
Times cited: 18
Neoadjuvant therapy of esophageal cancer. The cancer journal from Scientific American. 1997 Comment GET IT
Times cited: 4
Phase II study of ZD1694 in patients with advanced gastric cancer. American journal of clinical oncology. 1996 Academic Article GET IT
Times cited: 9
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue. Cancer. 1996 Academic Article GET IT
Times cited: 8
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 138
Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Seminars in oncology. 1996 Academic Article GET IT
Times cited: 14
Management of esophageal cancer. Oncology (Williston Park, N.Y.). 1996 Review GET IT
Times cited: 15
Neoadjuvant therapy for upper gastrointestinal tract cancers. Current opinion in oncology. 1996 Review GET IT
Times cited: 14
Adjuvant and neoadjuvant therapy for gastric cancer. Seminars in oncology. 1996 Review GET IT
Times cited: 104
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 114
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
The role of chemotherapy in the treatment of adenocarcinoma of the pancreas. Hepato-gastroenterology. 1996 Review GET IT
Times cited: 24
Adjuvant therapy of upper gastrointestinal tract cancers. Seminars in oncology. 1995 Review GET IT
Times cited: 12
The activity of paclitaxel in gastrointestinal tumors. Seminars in oncology. 1995 Academic Article GET IT
Times cited: 17
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 110
Chemotherapy and combined-modality therapy for esophageal cancer. Chest. 1995 Review GET IT
Times cited: 34
Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change. Cancer genetics and cytogenetics. 1995 Academic Article GET IT
Times cited: 26
Paclitaxel in the treatment of carcinoma of the esophagus. Seminars in oncology. 1995 Academic Article GET IT
Times cited: 26
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer. 1995 Academic Article GET IT
Times cited: 32
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1995 Academic Article GET IT
Times cited: 94
Pain and depression in patients with newly diagnosed pancreas cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 178
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. International journal of cancer. 1995 Academic Article GET IT
Times cited: 94
Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 1995 Academic Article GET IT
Times cited: 26
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Cancer investigation. 1995 Academic Article GET IT
Times cited: 11
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance. Cancer. 1994 Academic Article GET IT
Times cited: 13
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer. 1994 Academic Article GET IT
Times cited: 33
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report. Seminars in oncology. 1994 Academic Article GET IT
Times cited: 14
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer. 1994 Academic Article GET IT
Times cited: 73
Combined modality therapy in the treatment of esophageal cancer. Seminars in oncology. 1994 Review GET IT
Times cited: 75
Esophageal cancer. Seminars in oncology. 1994 Editorial Article GET IT
Times cited: 7
The use of chemotherapy in the treatment of advanced gastric and pancreas cancer. Seminars in oncology. 1994 Review GET IT
Times cited: 39
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. Journal of the National Cancer Institute. 1994 Academic Article GET IT
Times cited: 259
Adjuvant postoperative therapy of gastrointestinal malignancies. Oncology (Williston Park, N.Y.). 1994 Review GET IT
Times cited: 2
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 171
The role of chemotherapy in the treatment of esophageal cancer. Chest surgery clinics of North America. 1994 Review GET IT
Times cited: 3
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer. 1994 Academic Article GET IT
Times cited: 128
Defining the invasive phenotype of proximal gastric cancer cells. Cancer. 1994 Academic Article GET IT
Times cited: 37
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Investigational new drugs. 1994 Academic Article GET IT
Times cited: 434
Phase II trial of gemcitabine in patients with advanced gastric cancer. Cancer. 1994 Academic Article GET IT
Times cited: 28
Interphase cytogenetics of gastric and esophageal adenocarcinomas. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 1993 Academic Article GET IT
Times cited: 28
Neoadjuvant therapy for gastrointestinal cancers. Oncology (Williston Park, N.Y.). 1993 Review GET IT
Times cited: 14
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential. Cancer. 1993 Academic Article GET IT
Times cited: 49
A phase II trial of carboplatin in patients with advanced APUD tumors. Cancer. 1993 Academic Article GET IT
Times cited: 26
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer. 1993 Academic Article GET IT
Times cited: 269
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer. 1993 Academic Article GET IT
Times cited: 107
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 6
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1993 Academic Article GET IT
Times cited: 59
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 132
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 52
Combined-modality therapy in the treatment of local-regional esophageal cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1992 Review GET IT
Times cited: 11
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. Investigational new drugs. 1992 Academic Article GET IT
Times cited: 19
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. Cancer. 1992 Academic Article GET IT
Times cited: 8
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 186
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma. Investigational new drugs. 1992 Academic Article GET IT
Times cited: 20
Menogaril in the treatment of malignant mesothelioma: a phase II study. Investigational new drugs. 1992 Academic Article GET IT
Times cited: 13
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 88
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 287
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 41
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. Journal of cancer research and clinical oncology. 1992 Academic Article GET IT
Times cited: 119
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 232
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. International journal of radiation oncology, biology, physics. 1992 Academic Article GET IT
Times cited: 20
Adjuvant therapy of upper gastrointestinal tract cancers. Seminars in oncology. 1991 Review GET IT
Times cited: 10
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma. Cancer. 1991 Academic Article GET IT
Times cited: 83
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 122
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer. 1991 Academic Article GET IT
Times cited: 85
A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer. 1991 Academic Article GET IT
Times cited: 21
Adjuvant postoperative radiation therapy for resectable rectal cancer. Radiation medicine. 1991 Academic Article GET IT
Therapy of upper gastrointestinal tract cancers. Current problems in cancer. 1991 Review GET IT
Times cited: 27
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity. Cancer. 1990 Academic Article GET IT
Times cited: 130
A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies. Cancer. 1990 Academic Article GET IT
Times cited: 6
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer research. 1990 Academic Article GET IT
Times cited: 104
Gene amplification in gastric and esophageal adenocarcinomas. Cancer research. 1990 Academic Article GET IT
Times cited: 159
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma. Cancer. 1990 Academic Article GET IT
Times cited: 66
Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach. Investigational new drugs. 1990 Academic Article GET IT
Times cited: 3
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 149
Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes. Cancer. 1990 Academic Article GET IT
Times cited: 101
Infrequent point mutations of ras oncogenes in gastric cancers. Gastroenterology. 1990 Academic Article GET IT
Times cited: 69
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results. American journal of clinical oncology. 1990 Academic Article GET IT
Times cited: 49
Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract. Investigational new drugs. 1990 Academic Article GET IT
Times cited: 2
A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors. Cancer investigation. 1990 Academic Article GET IT
Neoadjuvant chemotherapy and surgery of cancer of the esophagus. Seminars in surgical oncology. 1990 Review GET IT
Times cited: 29
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine. Journal of the National Cancer Institute. 1989 Academic Article GET IT
Times cited: 23
Neoadjuvant therapy of esophageal cancer. Canadian journal of surgery. Journal canadien de chirurgie. 1989 Academic Article GET IT
Times cited: 6
Small cell carcinoma of the esophagus. The Memorial Hospital experience 1970 to 1987. Cancer. 1989 Academic Article GET IT
Times cited: 89
Flow cytometry as a predictive indicator in patients with operable gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1989 Academic Article GET IT
Times cited: 57
Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound. Gastrointestinal endoscopy. 1989 Academic Article GET IT
Times cited: 64
Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity. Investigational new drugs. 1988 Academic Article GET IT
Times cited: 9
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors. American journal of clinical oncology. 1988 Academic Article GET IT
Times cited: 36
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer. Cancer research. 1988 Academic Article GET IT
Times cited: 20
Chemotherapy of gastric cancer: a review. Israel journal of medical sciences. 1988 Review GET IT
Times cited: 12
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 7
Phase II trial of mitoxantrone in advanced gastric cancer. Oncology. 1988 Academic Article GET IT
Times cited: 2
Phase II trial of mitomycin in malignant mesothelioma. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 45
Radiation-induced angiosarcoma. Cancer. 1987 Review GET IT
Times cited: 92
Preoperative chemotherapy in esophageal carcinoma. World journal of surgery. 1987 Academic Article GET IT
Times cited: 16
Multimodality therapy of esophageal carcinoma: still an experimental approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Editorial Article GET IT
Times cited: 8
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 9
Phase II trial of etoposide in APUD tumors. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 24
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 5
Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 14
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 221
Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus. Cancer treatment reports. 1986 Academic Article GET IT
Times cited: 4
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer treatment reports. 1986 Academic Article GET IT
Times cited: 89
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer. Cancer treatment reports. 1986 Academic Article GET IT
Times cited: 43
Chemotherapy of gastric cancer. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 1986 Academic Article GET IT
Neoadjuvant chemotherapy and surgery of cancer of the esophagus. Seminars in surgical oncology. 1986 Review GET IT
Times cited: 22
Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 21
Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer. 1985 Academic Article GET IT
Times cited: 85
Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 36
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 72
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Times cited: 314
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer. American journal of clinical oncology. 1985 Academic Article GET IT
Times cited: 13
Chemotherapy of metastatic sweat gland carcinoma. A retrospective review. American journal of clinical oncology. 1985 Academic Article GET IT
Times cited: 30
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 21
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 80
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 84
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment. Chest. 1985 Academic Article GET IT
Times cited: 24
Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations. American journal of clinical oncology. 1985 Academic Article GET IT
Times cited: 53
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 1985 Academic Article GET IT
Times cited: 181
Chemotherapy of esophageal cancer. European journal of cancer & clinical oncology. 1985 Editorial Article GET IT
Times cited: 4
Chemotherapy-based multi-modality therapy of esophageal cancer. Progress in clinical and biological research. 1985 Review GET IT
Times cited: 1
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium). Cancer investigation. 1985 Academic Article GET IT
Times cited: 8
Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report. Cancer. 1984 Academic Article GET IT
Times cited: 49
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 7
Chemotherapy of esophageal cancer. Seminars in oncology. 1984 Review GET IT
Times cited: 79
Combined-modality therapy of esophageal cancer. Seminars in oncology. 1984 Review GET IT
Times cited: 26
Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 4
Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 88
Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate. Anticancer research. 1984 Academic Article GET IT
Times cited: 15
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer. Cancer chemotherapy and pharmacology. 1984 Academic Article GET IT
Times cited: 10
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. The American journal of medicine. 1983 Academic Article GET IT
Times cited: 99
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma. American journal of clinical oncology. 1983 Academic Article GET IT
Phase II trial of PCNU in non-small cell lung cancer. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 7
Vindesine in the treatment of malignant mesothelioma: a phase II study. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 27
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 21
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 16
Phase II study of etoposide in the treatment of esophageal carcinoma. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 18
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer. Cancer. 1983 Academic Article GET IT
Times cited: 24
Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 144
Phase II trial of PALA in hypernephroma and urinary bladder cancer. Cancer treatment reports. 1982 Academic Article GET IT
Times cited: 14
Treatment of advanced esophageal cancer. Cancer. 1982 Academic Article GET IT
Times cited: 28
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II). Cancer research. 1982 Academic Article GET IT
Times cited: 30
Treatment of esophageal carcinoma combined preoperative chemotherapy. The Annals of thoracic surgery. 1982 Academic Article GET IT
Times cited: 37
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma. American journal of clinical oncology. 1982 Academic Article GET IT
Times cited: 3
Phase II study of methyl-GAG in the treatment of esophageal carcinoma. Cancer treatment reports. 1982 Academic Article GET IT
Times cited: 10
Pharmacokinetics of cisplatin regional hepatic infusions. American journal of clinical oncology. 1982 Academic Article GET IT
Phase II trials of methylglyoxal-bis (guanylhydrazone). American journal of clinical oncology. 1982 Academic Article GET IT
Times cited: 4
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin. Cancer. 1982 Academic Article GET IT
Times cited: 44
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. Cancer treatment reports. 1982 Academic Article GET IT
Times cited: 26
Phase II trial of VP-16-213 in non-small-cell lung cancer. American journal of clinical oncology. 1982 Academic Article GET IT
Times cited: 8
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC). Cancer chemotherapy and pharmacology. 1982 Academic Article GET IT
Times cited: 22
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. The New England journal of medicine. 1981 Academic Article GET IT
Times cited: 597
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Annals of internal medicine. 1981 Academic Article GET IT
Times cited: 325
Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center. World journal of surgery. 1981 Academic Article GET IT
Times cited: 3
Combined modality therapy of esophageal carcinoma. Cancer. 1981 Academic Article GET IT
Times cited: 42
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion. Cancer research. 1981 Academic Article GET IT
Times cited: 17
Advances in chemotherapy of esophageal cancer. 1981 GET IT
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma. Cancer treatment reports. 1981 Academic Article GET IT
Times cited: 23
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum. Cancer clinical trials. 1981 Academic Article GET IT
Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer. Cancer clinical trials. 1981 Academic Article GET IT
Times cited: 4
Pharmacokinetics of gallium nitrate in man. Cancer. 1980 Academic Article GET IT
Times cited: 77
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone. 1980 GET IT
Times cited: 116
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer. Cancer treatment reports. 1980 Academic Article GET IT
Times cited: 17
Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung. Cancer treatment reports. 1980 Academic Article GET IT
Times cited: 18
Preclinical and phase I studies of malonatoplatinum. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1980 Academic Article GET IT
Times cited: 9
Philadelphia chromosome positive chronic myelogenous leukemia developing in a patient with acute lymphoblastic leukemia. 1979 GET IT
Times cited: 10
Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer. Cancer treatment reports. 1979 Academic Article GET IT
Times cited: 56
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II). Cancer treatment reports. 1979 Academic Article GET IT
Times cited: 20
Vindesine in the treatment of esophageal carcinoma: a phase II study. Cancer treatment reports. 1979 Academic Article GET IT
Times cited: 40
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas. Cancer treatment reports. 1978 Academic Article GET IT
Times cited: 45

more ...

less ...

Background

education and training

M.D., Medical College of Pennsylvania and Hahnemann University 1972
B.A., Temple University 1968

Contact

full name

David Kelsen

VIVO Weill Cornell Medical College

David Kelsen Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name